How many emend capsules are in a treatment course?

How many Emend capsules are in a treatment course

Emend contains aprepitant and is used to prevent nausea and vomiting caused by chemotherapy. A standard treatment course uses 3 capsules: one 125 mg capsule taken 1 hour before chemotherapy on day 1, followed by 80 mg capsules on day 2 and day 3.

How long does a treatment course last

A treatment course spans 3 days, matching the usual chemotherapy-induced nausea and vomiting schedule. The first capsule is taken 1 hour before chemo, then two more am.

How does Emend compare with other NK1 antagonists

Emend is one of the first NK1 receptor antagonists approved for CINV prevention. Other options such as rolapitant and netupitant work similar mechanisms but have different dosing schedules. Rolapitant has a single-dose regimen, whereas netupitant is combined with palonosetron in a single capsule.

When does the Emend patent expire

The patent covering the compound itself expired in 2015. Composition and method-of-use patents held by Merck expired or were challenged by generic manufacturers. Generic versions entered the U.S. market in 2015.

Who makes Emend

Merck manufactures the brand-name Emend. Generic versions are produced by several companies, including Teva, Dr. Reddy's, and Dr. Reddy's.

What side effects are patients asking about

Patients report common side effects such as fatigue, constipation, and hiccups. Hiccups are a distinctive feature of aprepitant.